307 related articles for article (PubMed ID: 30865314)
1. Fatal acute hemolytic transfusion reaction due to anti-B from a platelet apheresis unit stored in platelet additive solution.
Balbuena-Merle R; West FB; Tormey CA; Hendrickson JE
Transfusion; 2019 Jun; 59(6):1911-1915. PubMed ID: 30865314
[TBL] [Abstract][Full Text] [Related]
2. ABO antibody titers are not predictive of hemolytic reactions due to plasma-incompatible platelet transfusions.
Karafin MS; Blagg L; Tobian AA; King KE; Ness PM; Savage WJ
Transfusion; 2012 Oct; 52(10):2087-93. PubMed ID: 22339320
[TBL] [Abstract][Full Text] [Related]
3. Probiotic-associated high-titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactions.
Daniel-Johnson J; Leitman S; Klein H; Alter H; Lee-Stroka A; Scheinberg P; Pantin J; Quillen K
Transfusion; 2009 Sep; 49(9):1845-9. PubMed ID: 19453987
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of changes in hemoglobin levels associated with ABO-incompatible plasma in apheresis platelets.
Mair B; Benson K
Transfusion; 1998 Jan; 38(1):51-5. PubMed ID: 9482394
[TBL] [Abstract][Full Text] [Related]
5. PAS-C platelets contain less plasma protein, lower anti-A and anti-B titers, and decreased HLA antibody specificities compared to plasma platelets.
Weisberg SP; Shaz BH; Tumer G; Silliman CC; Kelher MR; Cohn CS
Transfusion; 2018 Apr; 58(4):891-895. PubMed ID: 29473178
[TBL] [Abstract][Full Text] [Related]
6. Evaluating safety and cost-effectiveness of platelets stored in additive solution (PAS-F) as a hemolysis risk mitigation strategy.
Pagano MB; Katchatag BL; Khoobyari S; Van Gerwen M; Sen N; Rebecca Haley N; Gernsheimer TB; Hess JR; Metcalf RA
Transfusion; 2019 Apr; 59(4):1246-1251. PubMed ID: 30592057
[TBL] [Abstract][Full Text] [Related]
7. How we treat: risk mitigation for ABO-incompatible plasma in plateletpheresis products.
Fontaine MJ; Mills AM; Weiss S; Hong WJ; Viele M; Goodnough LT
Transfusion; 2012 Oct; 52(10):2081-5. PubMed ID: 22414003
[No Abstract] [Full Text] [Related]
8. Significant numbers of apheresis-derived group O platelet units have "high-titer" anti-A/A,B: implications for transfusion policy.
Josephson CD; Mullis NC; Van Demark C; Hillyer CD
Transfusion; 2004 Jun; 44(6):805-8. PubMed ID: 15157243
[TBL] [Abstract][Full Text] [Related]
9. ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies.
Josephson CD; Castillejo MI; Grima K; Hillyer CD
Transfus Apher Sci; 2010 Feb; 42(1):83-8. PubMed ID: 20034854
[TBL] [Abstract][Full Text] [Related]
10. Repeat ABO-incompatible platelet transfusions leading to haemolytic transfusion reaction.
Sadani DT; Urbaniak SJ; Bruce M; Tighe JE
Transfus Med; 2006 Oct; 16(5):375-9. PubMed ID: 16999762
[TBL] [Abstract][Full Text] [Related]
11. Easier said than done: ABO compatibility and D matching in apheresis platelet transfusions.
Dunbar NM; Katus MC; Freeman CM; Szczepiorkowski ZM
Transfusion; 2015 Aug; 55(8):1882-8. PubMed ID: 25757728
[TBL] [Abstract][Full Text] [Related]
12. Seasonal variability is not observed in the rates of high anti-A and anti-B titers in plasma, apheresis platelet, and whole blood units tested by different methods.
Harm SK; Yazer MH; Bub CB; Cohn CS; Jacob EK; Kutner JM; Mair DC; Raval JS; Shaz BH; Ziman A; Dunbar NM;
Transfusion; 2019 Feb; 59(2):762-767. PubMed ID: 30548267
[TBL] [Abstract][Full Text] [Related]
13. When O Bites Back: Unrecognized Acute Hemolytic Reaction from Out-of-Group HLA-Compatible Platelet Transfusion.
Pasion JO; Song LH; McCusker MG; Shimer L; Bryant A; McGann HL; Fontaine MJ
Ann Clin Lab Sci; 2021 Mar; 51(2):267-270. PubMed ID: 33941569
[TBL] [Abstract][Full Text] [Related]
14. Hemolysis following platelet transfusions from ABO-incompatible donors.
Pierce RN; Reich LM; Mayer K
Transfusion; 1985; 25(1):60-2. PubMed ID: 2578692
[TBL] [Abstract][Full Text] [Related]
15. ABO compatibility can influence the results of platelet transfusion. Results of a randomized trial.
Lee EJ; Schiffer CA
Transfusion; 1989 Jun; 29(5):384-9. PubMed ID: 2660333
[TBL] [Abstract][Full Text] [Related]
16. Transfusion-related adverse events in the Platelet Dose study.
Kaufman RM; Assmann SF; Triulzi DJ; Strauss RG; Ness P; Granger S; Slichter SJ
Transfusion; 2015 Jan; 55(1):144-53. PubMed ID: 25065959
[TBL] [Abstract][Full Text] [Related]
17. Acute hemolytic transfusion reaction due to anti-Le(b).
Irani MS; Figueroa D; Savage G
Transfusion; 2015 Oct; 55(10):2486-8. PubMed ID: 26018602
[TBL] [Abstract][Full Text] [Related]
18. Acute Hemolytic Transfusion Reaction Due to Pooled Platelets: A Rare but Serious Adverse Event.
Gammon R; Cook S; Trinkle A; Thomas K; Benson K
Lab Med; 2021 Mar; 52(2):202-204. PubMed ID: 32930724
[TBL] [Abstract][Full Text] [Related]
19. Anti-A and anti-B titers in pooled group O platelets are comparable to apheresis platelets.
Cooling LL; Downs TA; Butch SH; Davenport RD
Transfusion; 2008 Oct; 48(10):2106-13. PubMed ID: 18631162
[TBL] [Abstract][Full Text] [Related]
20. Rare antibody-associated hemolytic transfusion reaction and transfusion-related acute lung injury: a case report.
Beck TN; Young NG; Erickson ML; Prats I
BMC Surg; 2017 Apr; 17(1):48. PubMed ID: 28441942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
